M. P. Glauser

15.8k total citations · 5 hit papers
155 papers, 11.7k citations indexed

About

M. P. Glauser is a scholar working on Epidemiology, Infectious Diseases and Immunology. According to data from OpenAlex, M. P. Glauser has authored 155 papers receiving a total of 11.7k indexed citations (citations by other indexed papers that have themselves been cited), including 81 papers in Epidemiology, 62 papers in Infectious Diseases and 37 papers in Immunology. Recurrent topics in M. P. Glauser's work include Antibiotics Pharmacokinetics and Efficacy (35 papers), Antimicrobial Resistance in Staphylococcus (33 papers) and Infective Endocarditis Diagnosis and Management (29 papers). M. P. Glauser is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (35 papers), Antimicrobial Resistance in Staphylococcus (33 papers) and Infective Endocarditis Diagnosis and Management (29 papers). M. P. Glauser collaborates with scholars based in Switzerland, United States and Belgium. M. P. Glauser's co-authors include Thierry Calandra, Didier Heumann, Jacques Billé, J. D. Baumgartner, P Francioli, Philippe Moreillon, Gláucia Zanetti, Abraham I. Braude, Claudio Viscoli and Thierry Roger and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

M. P. Glauser

154 papers receiving 11.2k citations

Hit Papers

Treatment of Gram-Negativ... 1982 2026 1996 2011 1982 2000 1991 1994 1999 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Treatment of Gram-Negative Bacteremia and Shock with Human Antiserum to a MutantEscherichia coli
    1982 779 citations M. P. Glauser et al. profile →
  2. Protection from septic shock by neutralization of macrophage migration inhibitory factor
    2000 616 citations Thierry Calandra, Didier Le Roy et al. profile →
  3. Septic shock: pathogenesis
    1991 593 citations M. P. Glauser, J. D. Baumgartner et al. profile →
  4. CD14 Is a pattern recognition receptor
    1994 586 citations Jérôme Pugin, Didier Heumann et al. Immunity profile →
  5. Atherogenic Dyslipidemia in HIV-Infected Individuals Treated With Protease Inhibitors
    1999 498 citations M. P. Glauser et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
M. P. Glauser 4.3k 3.7k 2.8k 1.9k 1.6k 155 11.7k
Robert L. Danner 4.3k 1.0× 2.9k 0.8× 869 0.3× 903 0.5× 676 0.4× 193 12.2k
Aseem Kumar 4.9k 1.2× 1.2k 0.3× 1.1k 0.4× 795 0.4× 1.8k 1.1× 69 9.5k
Evangelos J. Giamarellos‐Bourboulis 4.4k 1.0× 3.8k 1.0× 2.1k 0.8× 747 0.4× 518 0.3× 436 13.7k
Roberto Cauda 4.0k 0.9× 785 0.2× 5.5k 2.0× 1.1k 0.6× 1.5k 0.9× 330 12.2k
Jérôme Pugin 4.7k 1.1× 4.5k 1.2× 1.1k 0.4× 566 0.3× 684 0.4× 183 14.0k
Rein Saral 4.0k 0.9× 1.4k 0.4× 2.7k 1.0× 3.4k 1.8× 424 0.3× 134 11.3k
Lowell S. Young 2.8k 0.7× 515 0.1× 2.0k 0.7× 2.4k 1.3× 1.3k 0.8× 123 6.8k
Joseph P. Lynch 4.2k 1.0× 2.1k 0.6× 1.6k 0.6× 1.5k 0.8× 314 0.2× 270 18.6k
George H. McCracken 10.8k 2.5× 1.3k 0.4× 2.9k 1.0× 492 0.3× 827 0.5× 406 18.9k
Walter T. Hughes 6.5k 1.5× 499 0.1× 4.3k 1.6× 3.1k 1.7× 1.2k 0.8× 216 10.3k

Countries citing papers authored by M. P. Glauser

Since Specialization
Citations

This map shows the geographic impact of M. P. Glauser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. P. Glauser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. P. Glauser more than expected).

Fields of papers citing papers by M. P. Glauser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. P. Glauser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. P. Glauser. The network helps show where M. P. Glauser may publish in the future.

Co-authorship network of co-authors of M. P. Glauser

This figure shows the co-authorship network connecting the top 25 collaborators of M. P. Glauser. A scholar is included among the top collaborators of M. P. Glauser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. P. Glauser. M. P. Glauser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Viscoli, Claudio, Alain Cometta, Winfried V. Kern, et al.. (2006). Piperacillin–tazobactam monotherapy in high-risk febrile and neutropenic cancer patients. Clinical Microbiology and Infection. 12(3). 212–216. 56 indexed citations
2.
Glauser, M. P., U. Brennscheidt, Oliver A. Cornely, et al.. (2002). Clinafloxacin monotherapy (CI-960) versus ceftazidime plus amikacin for empirical treatment of febrile neutropenic cancer patients. Clinical Microbiology and Infection. 8(1). 14–25. 5 indexed citations
3.
Roy, Didier Le, Franco Di Padova, Yoshiyuki Adachi, et al.. (2001). Critical Role of Lipopolysaccharide-Binding Protein and CD14 in Immune Responses against Gram-Negative Bacteria. The Journal of Immunology. 167(5). 2759–2765. 75 indexed citations
4.
Viscoli, Claudio, Marianne Paesmans, Miguel Á. Sanz, et al.. (2001). Association between Antifungal Prophylaxis and Rate of Documented Bacteremia in Febrile Neutropenic Cancer Patients. Clinical Infectious Diseases. 32(11). 1532–1537. 28 indexed citations
5.
Abraham, Edward, Michael A. Matthay, Charles A. Dinarello, et al.. (2000). Consensus conference definitions for sepsis, septic shock, acute lung injury, and acute respiratory distress syndrome: Time for a reevaluation. Critical Care Medicine. 28(1). 232–235. 263 indexed citations
6.
Glauser, M. P.. (2000). Pathophysiologic basis of sepsis: Considerations for future strategies of intervention. Critical Care Medicine. 28(Supplement). S4–S8. 78 indexed citations
7.
Glauser, M. P.. (2000). Neutropenia: clinical implications and modulation. Intensive Care Medicine. 26(0). S103–S110. 6 indexed citations
8.
Glauser, M. P.. (1998). Empiric Therapy of Bacterial Infections in Patients with Severe Neutropenia. Diagnostic Microbiology and Infectious Disease. 31(3). 467–472. 18 indexed citations
9.
Heumann, Didier, M. P. Glauser, & Thierry Calandra. (1998). Molecular basis of host—pathogen interaction in septic shock. Current Opinion in Microbiology. 1(1). 49–55. 85 indexed citations
10.
Glauser, M. P., Marc Boogaerts, Catherine Cordonnier, Jan Palmblad, & Pietro Martino. (1997). Empiric therapy of bacterial infections in severe neutropenia. Clinical Microbiology and Infection. 3. S77–S86. 16 indexed citations
11.
Glauser, M. P.. (1997). 8th European Congress of Clinical Microbiology and Infectious Diseases Lausanne, Switzerland, May 25–28, 1997. Clinical Microbiology and Infection. 3(1). 1–1. 15 indexed citations
12.
Morawetz, Renate A., G. Paolo Rizzardi, Olivier Rutschmann, et al.. (1997). Genetic polymorphism of CCR5 gene and HIV disease: The heterozygous (CCR5/Δccr5) genotype is neither essential nor sufficient for protection against disease progression. European Journal of Immunology. 27(12). 3223–3227. 32 indexed citations
13.
Chave, Jean‐Philippe, Christian Durussel, M. P. Glauser, & Jacques Billé. (1996). Asymptomatic oral yeast carriage in HIV-infected patients: frequency and fluconazole susceptibility profile. Clinical Microbiology and Infection. 1(4). 249–252. 9 indexed citations
14.
Vincent, Jean‐Louis, L. G. Thijs, Konrad Reinhart, et al.. (1994). Task Force: Guidelines for the problem of sepsis (ESICM). Intensive Care Medicine. 20. 300–304. 21 indexed citations
15.
Pugin, Jérôme, Didier Heumann, Alexander Tomasz, et al.. (1994). CD14 Is a pattern recognition receptor. Immunity. 1(6). 509–516. 586 indexed citations breakdown →
16.
Flückiger, Ursula, P Francioli, J. Blaser, M. P. Glauser, & Philippe Moreillon. (1994). Role of Amoxicillin Serum Levels for Successful Prophylaxis of Experimental Endocarditis Due to Tolerant Streptococci. The Journal of Infectious Diseases. 169(6). 1397–1400. 35 indexed citations
17.
Heumann, Didier, et al.. (1994). Radioimmunoassay versus flow cytometric assay to quantify LPS-binding protein (LBP) concentrations in human plasma. Journal of Immunological Methods. 171(2). 169–176. 7 indexed citations
18.
Girardin, Éric, J. D. Baumgartner, François Beaufils, et al.. (1992). Treatment of severe infectious purpura in children with human plasma from donors immunized with Escherichia coli J5: a prospective double-blind study. J5 study Group.. IRIS. 60 indexed citations
19.
20.
Overholser, C. Daniel, Philippe Moreillon, & M. P. Glauser. (1988). Experimental endocarditis following dental extractions in rats with periodontitis. Journal of Oral and Maxillofacial Surgery. 46(10). 857–861. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robert L. Danner Breakdown of academic impact, for papers by Aseem Kumar Breakdown of academic impact, for papers by Evangelos J. Giamarellos‐Bourboulis Breakdown of academic impact, for papers by Roberto Cauda Breakdown of academic impact, for papers by Jérôme Pugin Breakdown of academic impact, for papers by Rein Saral Breakdown of academic impact, for papers by Lowell S. Young Breakdown of academic impact, for papers by Joseph P. Lynch Breakdown of academic impact, for papers by George H. McCracken Breakdown of academic impact, for papers by Walter T. Hughes
Rankless by CCL
2026